The Cancer Research Institute announces Lance Kawaguchi, CEO of Cure Brain Cancer Foundation as their new Strategic Advisor.
The Cancer Research Institute (CRI), established in 1953, is a top-rated U.S. non-profit organization dedicated exclusively to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers.
“Having witnessed the increased global exposure and effectiveness that Lance has brought to Cure Brain Cancer Foundation, specifically, and research into cancer, I’m excited that he’ll be an ambassador for the Cancer Research Institute in our fundraising initiatives,” states CRI CEO and Scientific Affairs Director Jill O’Donnell-Tormey, PhD.
“CRI’s laser-like focus on immunotherapy, the most transformative field in cancer medicine over the past generation, its legacy of having invested a half-billion dollars into research, and its Scientific Advisory Council, headed by Nobel laureate James P. Allison, PhD., and comprised of giants of science and medicine, are among the many features which set CRI apart from peers and that have appealed to me,” Mr. Kawaguchi elaborates. “I am honoured to have been asked to support the organization’s continuous improvement and enjoy working with organizations that value, appreciate, and respect the contributions I can make.”
Mr Kawaguchi is setting his sights on completing the Trek to the South Pole to raise funds for cancer this December. Over eight charity partners from around the world are participating in the Trek, which is a statement of human endurance.
“Over the past two years I’ve been impressed with the impact, approach, and dedication of the Cancer Research Institute and its leadership,” says Mr. Kawaguchi. “This is already a difference-making organization, and I look forward to helping it do even more important work on behalf of cancer patients.”
